These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10951228)

  • 21. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation.
    Mitsiades CS; Poulaki V; Fanourakis G; Sozopoulos E; McMillin D; Wen Z; Voutsinas G; Tseleni-Balafouta S; Mitsiades N
    Clin Cancer Res; 2006 Jun; 12(12):3705-12. PubMed ID: 16778096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.
    Poulaki V; Mitsiades CS; McMullan C; Fanourakis G; Negri J; Goudopoulou A; Halikias IX; Voutsinas G; Tseleni-Balafouta S; Miller JW; Mitsiades N
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):358-66. PubMed ID: 15623796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding.
    French LE; Trent JT; Kerdel FA
    Int Immunopharmacol; 2006 Apr; 6(4):543-9. PubMed ID: 16504917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Another cell death induction system: TNF-alpha acts as a ligand for Fas in vaginal cells.
    Suzuki A; Tsutomi Y; Shimizu M; Matsuzawa A
    Cell Death Differ; 1999 Jul; 6(7):638-43. PubMed ID: 10453074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A family of ligands for the TNF receptor superfamily.
    Cosman D
    Stem Cells; 1994 Sep; 12(5):440-55. PubMed ID: 7528588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
    Chopin V; Slomianny C; Hondermarck H; Le Bourhis X
    Exp Cell Res; 2004 Aug; 298(2):560-73. PubMed ID: 15265702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
    Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fas and other cell death signaling pathways.
    Depraetere V; Golstein P
    Semin Immunol; 1997 Apr; 9(2):93-107. PubMed ID: 9194220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mice lacking TNFalpha receptors 1 and 2 are resistant to death and fulminant liver injury induced by agonistic anti-Fas antibody.
    Costelli P; Aoki P; Zingaro B; Carbó N; Reffo P; Lopez-Soriano FJ; Bonelli G; Argilés JM; Baccino FM
    Cell Death Differ; 2003 Sep; 10(9):997-1004. PubMed ID: 12934074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe cutaneous adverse reactions to drugs.
    Chia FL; Leong KP
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyrocyte targets and effectors of autoimmunity: a role for death receptors?
    Hammond LJ; Palazzo FF; Shattock M; Goode AW; Mirakian R
    Thyroid; 2001 Oct; 11(10):919-27. PubMed ID: 11716038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case report: Successful immunomodulators combined with electromagnetic field therapy in a patient with methazolamide-induced Steven Johnson syndrome/toxic epidermal necrolysis overlap.
    Zhang N; Su T; Yan J; Zhang M; Zhao S; Liu C; Chen T
    Front Med (Lausanne); 2023; 10():1192920. PubMed ID: 37305125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal ω3 docosapentaenoic acid inhibits infant allergic dermatitis through TRAIL-expressing plasmacytoid dendritic cells in mice.
    Hirata SI; Nagatake T; Sawane K; Hosomi K; Honda T; Ono S; Shibuya N; Saito E; Adachi J; Abe Y; Isoyama J; Suzuki H; Matsunaga A; Tomonaga T; Kiyono H; Kabashima K; Arita M; Kunisawa J
    Allergy; 2020 Aug; 75(8):1939-1955. PubMed ID: 32027039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxic epidermal necrolysis and concurrent granulomatosis with polyangiitis (Wegener's granulomatosis). Management of a rare case and review of the literature.
    Sofos SS; Ewing J; Hughes LC; James MI
    Scars Burn Heal; 2016; 2():2059513116642129. PubMed ID: 29799572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidative Effect of Quetiapine on Acute Ultraviolet-B-Induced Skin and HaCaT Cell Damage.
    Xu P; Zhang M; Wang X; Yan Y; Chen Y; Wu W; Zhang L; Zhang L
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29570608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-CBL E3 Ubiquitin Ligase Expression Increases Across the Spectrum of Benign and Malignant T-Cell Skin Diseases.
    Salva KA; Reeder MJ; Lloyd R; Wood GS
    Am J Dermatopathol; 2017 Oct; 39(10):731-737. PubMed ID: 27805921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxic epidermal necrolysis.
    Hoetzenecker W; Mehra T; Saulite I; Glatz M; Schmid-Grendelmeier P; Guenova E; Cozzio A; French LE
    F1000Res; 2016; 5():. PubMed ID: 27239294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse cutaneous drug eruptions: current understanding.
    Hoetzenecker W; Nägeli M; Mehra ET; Jensen AN; Saulite I; Schmid-Grendelmeier P; Guenova E; Cozzio A; French LE
    Semin Immunopathol; 2016 Jan; 38(1):75-86. PubMed ID: 26553194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases.
    Marzano AV; Ceccherini I; Gattorno M; Fanoni D; Caroli F; Rusmini M; Grossi A; De Simone C; Borghi OM; Meroni PL; Crosti C; Cugno M
    Medicine (Baltimore); 2014 Dec; 93(27):e187. PubMed ID: 25501066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.